vs
北极星（PII）与福泰制药（VRTX）财务数据对比。点击上方公司名可切换其他公司
福泰制药的季度营收约是北极星的1.9倍（$3.2B vs $1.7B），福泰制药净利率更高（37.3% vs -2.8%，领先40.2%），福泰制药同比增速更快（9.5% vs 8.0%），福泰制药自由现金流更多（$348.6M vs $-342.5M），过去两年福泰制药的营收复合增速更高（8.9% vs -8.0%）
北极星公司（Polaris Inc.）是总部位于美国明尼苏达州麦地那的机动车制造企业，创立于明尼苏达州罗索，当地目前仍保留其工程研发与生产设施。公司曾通过胜利摩托子公司生产摩托车，2011年收购印第安摩托品牌后转由该子公司运营摩托业务，此前还曾生产私人水上摩托艇产品。
福泰制药是总部位于美国马萨诸塞州波士顿的生物制药企业，是全球首批明确采用理性药物设计策略、而非组合化学方法开发药物的生物技术公司之一。除波士顿总部外，公司还在加州圣迭戈、英国牛津郡米尔顿公园设有三处研发中心。
PII vs VRTX — 直观对比
营收规模更大
VRTX
是对方的1.9倍
$1.7B
营收增速更快
VRTX
高出1.5%
8.0%
净利率更高
VRTX
高出40.2%
-2.8%
自由现金流更多
VRTX
多$691.1M
$-342.5M
两年增速更快
VRTX
近两年复合增速
-8.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $3.2B |
| 净利润 | $-47.2M | $1.2B |
| 毛利率 | 20.2% | 85.4% |
| 营业利润率 | — | 37.8% |
| 净利率 | -2.8% | 37.3% |
| 营收同比 | 8.0% | 9.5% |
| 净利润同比 | 29.2% | 30.5% |
| 每股收益（稀释后） | $-0.83 | $4.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PIIVRTX
| Q1 26 | $1.7B | — | ||
| Q4 25 | $1.9B | $3.2B | ||
| Q3 25 | $1.8B | $3.1B | ||
| Q2 25 | $1.9B | $3.0B | ||
| Q1 25 | $1.5B | $2.8B | ||
| Q4 24 | $1.8B | $2.9B | ||
| Q3 24 | $1.7B | $2.8B | ||
| Q2 24 | $2.0B | $2.6B |
净利润PIIVRTX
| Q1 26 | $-47.2M | — | ||
| Q4 25 | $-303.6M | $1.2B | ||
| Q3 25 | $-15.8M | $1.1B | ||
| Q2 25 | $-79.3M | $1.0B | ||
| Q1 25 | $-66.8M | $646.3M | ||
| Q4 24 | $10.6M | $913.0M | ||
| Q3 24 | $27.7M | $1.0B | ||
| Q2 24 | $68.7M | $-3.6B |
毛利率PIIVRTX
| Q1 26 | 20.2% | — | ||
| Q4 25 | 20.0% | 85.4% | ||
| Q3 25 | 20.7% | 86.5% | ||
| Q2 25 | 19.4% | 86.3% | ||
| Q1 25 | 16.0% | 86.9% | ||
| Q4 24 | 20.4% | 85.5% | ||
| Q3 24 | 20.6% | 85.8% | ||
| Q2 24 | 21.6% | 85.9% |
营业利润率PIIVRTX
| Q1 26 | — | — | ||
| Q4 25 | -16.7% | 37.8% | ||
| Q3 25 | 1.1% | 38.6% | ||
| Q2 25 | -0.7% | 38.8% | ||
| Q1 25 | -2.4% | 22.7% | ||
| Q4 24 | 3.7% | 35.2% | ||
| Q3 24 | 3.8% | 40.3% | ||
| Q2 24 | 6.1% | -132.9% |
净利率PIIVRTX
| Q1 26 | -2.8% | — | ||
| Q4 25 | -15.8% | 37.3% | ||
| Q3 25 | -0.9% | 35.2% | ||
| Q2 25 | -4.3% | 34.8% | ||
| Q1 25 | -4.3% | 23.3% | ||
| Q4 24 | 0.6% | 31.4% | ||
| Q3 24 | 1.6% | 37.7% | ||
| Q2 24 | 3.5% | -135.8% |
每股收益（稀释后）PIIVRTX
| Q1 26 | $-0.83 | — | ||
| Q4 25 | $-5.34 | $4.64 | ||
| Q3 25 | $-0.28 | $4.20 | ||
| Q2 25 | $-1.39 | $3.99 | ||
| Q1 25 | $-1.17 | $2.49 | ||
| Q4 24 | $0.18 | $3.62 | ||
| Q3 24 | $0.49 | $4.01 | ||
| Q2 24 | $1.21 | $-13.92 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $282.0M | $6.6B |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $750.4M | $18.7B |
| 总资产 | $5.2B | $25.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资PIIVRTX
| Q1 26 | $282.0M | — | ||
| Q4 25 | $138.0M | $6.6B | ||
| Q3 25 | $335.5M | $6.3B | ||
| Q2 25 | $324.3M | $6.4B | ||
| Q1 25 | $291.7M | $6.2B | ||
| Q4 24 | $287.8M | $6.1B | ||
| Q3 24 | $291.3M | $6.5B | ||
| Q2 24 | $322.7M | $5.8B |
总债务PIIVRTX
| Q1 26 | — | — | ||
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.6B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.7B | — | ||
| Q2 24 | $2.1B | — |
股东权益PIIVRTX
| Q1 26 | $750.4M | — | ||
| Q4 25 | $828.4M | $18.7B | ||
| Q3 25 | $1.1B | $17.3B | ||
| Q2 25 | $1.2B | $17.2B | ||
| Q1 25 | $1.2B | $16.5B | ||
| Q4 24 | $1.3B | $16.4B | ||
| Q3 24 | $1.3B | $15.6B | ||
| Q2 24 | $1.3B | $14.8B |
总资产PIIVRTX
| Q1 26 | $5.2B | — | ||
| Q4 25 | $4.9B | $25.6B | ||
| Q3 25 | $5.3B | $24.9B | ||
| Q2 25 | $5.4B | $24.0B | ||
| Q1 25 | $5.5B | $22.9B | ||
| Q4 24 | $5.5B | $22.5B | ||
| Q3 24 | $5.6B | $22.2B | ||
| Q2 24 | $5.7B | $20.1B |
负债/权益比PIIVRTX
| Q1 26 | — | — | ||
| Q4 25 | 1.82× | — | ||
| Q3 25 | 1.13× | — | ||
| Q2 25 | 1.17× | — | ||
| Q1 25 | 1.32× | — | ||
| Q4 24 | 1.27× | — | ||
| Q3 24 | 1.29× | — | ||
| Q2 24 | 1.56× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $498.0M |
| 自由现金流经营现金流 - 资本支出 | $-342.5M | $348.6M |
| 自由现金流率自由现金流/营收 | -20.6% | 10.9% |
| 资本支出强度资本支出/营收 | — | 4.7% |
| 现金转化率经营现金流/净利润 | — | 0.42× |
| 过去12个月自由现金流最近4个季度 | $168.0M | $3.2B |
8季度趋势，按日历期对齐
经营现金流PIIVRTX
| Q1 26 | — | — | ||
| Q4 25 | $178.7M | $498.0M | ||
| Q3 25 | $158.8M | $1.2B | ||
| Q2 25 | $320.3M | $1.1B | ||
| Q1 25 | $83.2M | $818.9M | ||
| Q4 24 | $206.3M | $584.6M | ||
| Q3 24 | $21.0M | $1.4B | ||
| Q2 24 | $146.3M | $-3.8B |
自由现金流PIIVRTX
| Q1 26 | $-342.5M | — | ||
| Q4 25 | $114.0M | $348.6M | ||
| Q3 25 | $116.7M | $1.1B | ||
| Q2 25 | $279.8M | $927.4M | ||
| Q1 25 | $47.6M | $778.2M | ||
| Q4 24 | $137.3M | $492.0M | ||
| Q3 24 | $-32.4M | $1.3B | ||
| Q2 24 | $79.1M | $-3.8B |
自由现金流率PIIVRTX
| Q1 26 | -20.6% | — | ||
| Q4 25 | 5.9% | 10.9% | ||
| Q3 25 | 6.3% | 37.0% | ||
| Q2 25 | 15.1% | 31.3% | ||
| Q1 25 | 3.1% | 28.1% | ||
| Q4 24 | 7.8% | 16.9% | ||
| Q3 24 | -1.9% | 47.0% | ||
| Q2 24 | 4.0% | -144.5% |
资本支出强度PIIVRTX
| Q1 26 | — | — | ||
| Q4 25 | 3.4% | 4.7% | ||
| Q3 25 | 2.3% | 3.3% | ||
| Q2 25 | 2.2% | 4.9% | ||
| Q1 25 | 2.3% | 1.5% | ||
| Q4 24 | 3.9% | 3.2% | ||
| Q3 24 | 3.1% | 2.4% | ||
| Q2 24 | 3.4% | 2.6% |
现金转化率PIIVRTX
| Q1 26 | — | — | ||
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | 1.15× | ||
| Q2 25 | — | 1.04× | ||
| Q1 25 | — | 1.27× | ||
| Q4 24 | 19.46× | 0.64× | ||
| Q3 24 | 0.76× | 1.31× | ||
| Q2 24 | 2.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PII
暂无分部数据
VRTX
| TRIKAFTAKAFTRIO | $2.6B | 81% |
| ALYFTREK | $380.1M | 12% |
| Manufactured Product Other | $237.4M | 7% |
